TOPICS

Day: April 1, 2020

April 2020 Editorial Message

Vol. 13, No. 4 • April 2020 Dear Colleagues: Welcome to the April 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with original research from Kircik et al, titled, “Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris.” Here, the authors discuss the

CONTINUE READING »

Letter to the Editor: A Case of Morbilliform Drug Eruption to Dulaglutide

Dear Editor: Dulaglutide is a glucagon-like peptide (GLP-1) receptor agonist, which stimulates insulin release via activation of GLP-1 receptors on pancreatic beta cells. Here, we report the first case of morbilliform drug eruption to dulaglutide. Case presentation. An 84-year-old male patient with a medical history of Type 2 diabetes mellitus, hyperlipidemia, hypertension, and back pain

CONTINUE READING »